These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Direct interaction of Dysbindin with the AP-3 complex via its mu subunit. Taneichi-Kuroda S; Taya S; Hikita T; Fujino Y; Kaibuchi K Neurochem Int; 2009 Jun; 54(7):431-8. PubMed ID: 19428785 [TBL] [Abstract][Full Text] [Related]
3. Cytosolic protein interactions of the schizophrenia susceptibility gene dysbindin. Mead CL; Kuzyk MA; Moradian A; Wilson GM; Holt RA; Morin GB J Neurochem; 2010 Jun; 113(6):1491-503. PubMed ID: 20236384 [TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Behan AT; Byrne C; Dunn MJ; Cagney G; Cotter DR Mol Psychiatry; 2009 Jun; 14(6):601-13. PubMed ID: 18268500 [TBL] [Abstract][Full Text] [Related]
5. The sandy (sdy) mouse: a dysbindin-1 mutant relevant to schizophrenia research. Talbot K Prog Brain Res; 2009; 179():87-94. PubMed ID: 20302821 [TBL] [Abstract][Full Text] [Related]
6. Dysbindin engages in c-Jun N-terminal kinase activity and cytoskeletal organization. Kubota K; Kumamoto N; Matsuzaki S; Hashimoto R; Hattori T; Okuda H; Takamura H; Takeda M; Katayama T; Tohyama M Biochem Biophys Res Commun; 2009 Feb; 379(2):191-5. PubMed ID: 19094965 [TBL] [Abstract][Full Text] [Related]
7. [Risk genes for schizophrenia and neuronal plasticity: molecular target for antipsychotic discovery]. Hashimoto R; Yasuda Y; Ohi K; Fukumoto M; Yamamori H; Takeda M Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Jun; 30(3):103-7. PubMed ID: 20666140 [TBL] [Abstract][Full Text] [Related]
8. Proteomics- and transcriptomics-based screening of differentially expressed proteins and genes in brain of Wig rat: a model for attention deficit hyperactivity disorder (ADHD) research. Hirano M; Rakwal R; Shibato J; Sawa H; Nagashima K; Ogawa Y; Yoshida Y; Iwahashi H; Niki E; Masuo Y J Proteome Res; 2008 Jun; 7(6):2471-89. PubMed ID: 18457438 [TBL] [Abstract][Full Text] [Related]
9. Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin. Kumamoto N; Matsuzaki S; Inoue K; Hattori T; Shimizu S; Hashimoto R; Yamatodani A; Katayama T; Tohyama M Biochem Biophys Res Commun; 2006 Jun; 345(2):904-9. PubMed ID: 16701550 [TBL] [Abstract][Full Text] [Related]
10. Dysbindin and d-amino-acid-oxidase gene polymorphisms associated with positive and negative symptoms in schizophrenia. Wirgenes KV; Djurovic S; Agartz I; Jonsson EG; Werge T; Melle I; Andreassen OA Neuropsychobiology; 2009; 60(1):31-6. PubMed ID: 19729970 [TBL] [Abstract][Full Text] [Related]
11. The interaction of mammalian Class C Vps with nSec-1/Munc18-a and syntaxin 1A regulates pre-synaptic release. Kim BY; Sahara Y; Yamamoto A; Kominami E; Kohsaka S; Akazawa C Biochem Biophys Res Commun; 2006 Nov; 350(3):691-7. PubMed ID: 17027648 [TBL] [Abstract][Full Text] [Related]
12. The Proteome of BLOC-1 Genetic Defects Identifies the Arp2/3 Actin Polymerization Complex to Function Downstream of the Schizophrenia Susceptibility Factor Dysbindin at the Synapse. Gokhale A; Hartwig C; Freeman AH; Das R; Zlatic SA; Vistein R; Burch A; Carrot G; Lewis AF; Nelms S; Dickman DK; Puthenveedu MA; Cox DN; Faundez V J Neurosci; 2016 Dec; 36(49):12393-12411. PubMed ID: 27927957 [TBL] [Abstract][Full Text] [Related]
13. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Hattori S; Murotani T; Matsuzaki S; Ishizuka T; Kumamoto N; Takeda M; Tohyama M; Yamatodani A; Kunugi H; Hashimoto R Biochem Biophys Res Commun; 2008 Aug; 373(2):298-302. PubMed ID: 18555792 [TBL] [Abstract][Full Text] [Related]
14. Convergence of two independent mental disease genes on the protein level: recruitment of dysbindin to cell-invasive disrupted-in-schizophrenia 1 aggresomes. Ottis P; Bader V; Trossbach SV; Kretzschmar H; Michel M; Leliveld SR; Korth C Biol Psychiatry; 2011 Oct; 70(7):604-10. PubMed ID: 21531389 [TBL] [Abstract][Full Text] [Related]
15. Dysregulation of growth factor receptor-bound protein 2 and fascin in hippocampus of mice polytransgenic for chromosome 21 structures. Shin JH; Guedj F; Delabar JM; Lubec G Hippocampus; 2007; 17(12):1180-92. PubMed ID: 17696169 [TBL] [Abstract][Full Text] [Related]
16. Regulation of Brain-Derived Neurotrophic Factor Exocytosis and Gamma-Aminobutyric Acidergic Interneuron Synapse by the Schizophrenia Susceptibility Gene Dysbindin-1. Yuan Q; Yang F; Xiao Y; Tan S; Husain N; Ren M; Hu Z; Martinowich K; Ng JS; Kim PJ; Han W; Nagata KI; Weinberger DR; Je HS Biol Psychiatry; 2016 Aug; 80(4):312-322. PubMed ID: 26386481 [TBL] [Abstract][Full Text] [Related]
17. The schizophrenia susceptibility gene DTNBP1 modulates AMPAR synaptic transmission and plasticity in the hippocampus of juvenile DBA/2J mice. Orozco IJ; Koppensteiner P; Ninan I; Arancio O Mol Cell Neurosci; 2014 Jan; 58():76-84. PubMed ID: 24321452 [TBL] [Abstract][Full Text] [Related]
19. The proteome of the presynaptic active zone: from docked synaptic vesicles to adhesion molecules and maxi-channels. Morciano M; Beckhaus T; Karas M; Zimmermann H; Volknandt W J Neurochem; 2009 Feb; 108(3):662-75. PubMed ID: 19187093 [TBL] [Abstract][Full Text] [Related]
20. Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein. Nazarian R; Starcevic M; Spencer MJ; Dell'Angelica EC Biochem J; 2006 May; 395(3):587-98. PubMed ID: 16448387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]